Navigation Links
Northwest Secures US$1.0 Million Debt Financing
Date:10/1/2008

BETHESDA, Md., Oct. 2 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS), today announced that it has entered into a Loan Agreement and Promissory Note (the "Note") with SDS Capital Group SPC, Ltd ("SDS"). Under the Note, SDS has loaned the Company US$1,000,000. The Note is an unsecured obligation of the Company and accrues interest at the rate of 12% per year. The term of the Note is six months, with a maturity date of April 1, 2009. The Note may not be prepaid without the consent of SDS. The Note contains customary representations, warranties, and covenants. In connection with the Note, the Company has issued to SDS a warrant (the "Investment Warrant") to purchase up to 299,046 shares of the Company's common stock at an exercise price equal to US $0.53 per share, which was the closing price of the Company's common stock on the AIM market of the London Stock Exchange on October 1, 2008. The Investment Warrant is exercisable immediately, and expires 5 years from the date of issuance.

In addition to the Investment Warrant, under the terms of the Note, the Company issued SDS an additional warrant (the "Placement Warrant") to purchase up to 398,729 shares of the Company's common stock at an exercise price equal to US $0.53 per share. The Placement Warrant is on the same terms and conditions and in the same form as the Investment Warrant. Accordingly, the Placement Warrant is also exercisable immediately and expires 5 years after issuance.

The US$1,000,000 loan received by the Company will be sufficient to fund its cash needs into November 2008. The Company remains in advanced stage negotiations with several different providers for additional near-term funding of at least US$1,000,000, and for further financing transactions, which it hopes to complete by the end of the year.

The Company will need to raise additional capital to fund its clinical trials and other operating activities and to
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Northwestern chemists take gold, mass-produce Beijing Olympic logo
2. Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
3. Northwestern chemist investigates lost reds in Homer painting
4. Nikon Instruments Opens New Imaging Center at Northwestern University
5. Northwest Secures US$4.0 Million in Debt Financing
6. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
7. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
8. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
9. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
10. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
11. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCall/ ...mpleted transfer of Qutenza(TM) E.U. Marketing Aut...ignificant progress in commercial readiness activi...; Senior Director, Marketing; and Director, Commer...board as director and Audit Committee chairman ,...
(Date:11/6/2009)... The agenda for Arrowhead&rsqu...ence, which is set to take place on February 22-24...s three day conference we will highlight key issue...kers to share their experiences. , ... -- The agenda for Arrowhead’s 2010 Persona...
(Date:11/5/2009)... PARSIPPANY, N.J., Nov. 5 DSM Phar...de a manufacturing alliance with Galenix, Saint Je...d commercial scale manufacturing partner for Galen...M and Galenix will collaborate on business develop...ery technologies, based on the strength of Galenix...
(Date:11/5/2009)... OMAHA, Neb., Nov. 5 Tra...nnounced financial results for the quarter ended S... are presented in the tables that follow. ,, T...t loss of $366,000 or $0.01 per share for the thir...9,000 or $0.01 per share for the third quarter of ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
... N.J., Oct. 28 Millennium,Biotechnologies Group, ...at,Benjamin Custodio has joined the Company as Exe... member of the Board of Directors. Mr. Custodio,ha...l and nutritional,supplement industries, specializ...arkets., As Executive Vice President of Internati...
...tish Columbia, Oct. 28 ,ProtoKinetix Inc. (OTC Bul...he research, development and commercialization of ...ounced today that OTC Financial Network,(OTCFN), a...p. (NFC), has,issued a corporate profile on the Co...otoKinetix technology platform, its multiple comme...
...s., Oct. 28 Indevus,Pharmaceuticals, Inc. (Nasdaq...enting at the Oppenheimer 19th Annual Healthcare C...stern Time. The Company will also be,presenting at...rence on,Monday, November 10, 2008 at 9:30 AM East...ork City. The presentations will be web cast live ...
Other Biology Technology:Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 2Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 3OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc. 2OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc. 3Indevus Pharmaceuticals to Present at Upcoming Investor Conferences 2Indevus Pharmaceuticals to Present at Upcoming Investor Conferences 3
(Date:11/4/2009)...ientists are reluctant to officially endorse green...nues to grow about its protective effects, includi...vention Research , a journal of the American Assoc...duction in oral cancer. , Vassiliki Papadimitra...ment of Thoracic/Head and Neck Medical Oncology at...
(Date:11/4/2009)...teria, it turns out, hold the power to help milita... world clean up toxic waste on test sites. , Com... invented back in World War II and have been used ...rgy compounds are often used to propel tank shells... But with increased knowledge of their environmen...
(Date:11/4/2009)...0 Quest Diagnostics Inco...er of diagnostic testing, information and services...mber 30, 2009, income from continuing operations r...rom $160 million, or $0.81 per diluted share, for ...results were reduced by a $0.03 per share charge a...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 1Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 2Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 3New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 1New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 2New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 3New Research Suggests Strong Link Between Sweetened Caloric Beverages and Metabolic Syndrome 48857 1New Research Suggests Strong Link Between Sweetened Caloric Beverages and Metabolic Syndrome 48857 2New Research Suggests Strong Link Between Sweetened Caloric Beverages and Metabolic Syndrome 48857 3
...tbreaks of the notorious crown of thorns starfish ...r of coral reef biodiversity on Earth. , Thats th...Centre of Excellence for Coral Reef Studies and th... Zoo, USA. , The starfish a predator that feeds ... digestive enzymes to liquefy tissue was discover...
... an article published in the January 16 issue of P...titut de Cincies del Mar (CSIC) in Spain describe ...ng how a climate-driven phenomenon originated in s...s of a deep-sea living resource. , The progressiv...ocio-economical issues of the forthcoming century....
...OZEMAN -- The same brown algae that cover rocks an...oil that can be turned into diesel fuel, says a Mo...can,t pump algal fuel into their gas tanks yet, bu...elt that way 20 years ago. He feels that way today...been so short-sighted," Cooksey said. , Cooksey i...
Other Biology News:Starfish strike at coral kingdom 2Climate influence on deep sea populations 2Montana State University researcher finds renewed interest in turning algae into fuel 2Montana State University researcher finds renewed interest in turning algae into fuel 3
Horizontal Laminar Flow Work Station from Terra Universal, Inc.
...mbodies all aspects of classical microscopy in a s...tic Super Contrast (ASC) objectives coupled with a...icroscope combines flexibility and professional mi...1 series, the DM-B1 steps into the 21st century fe...
...enase Dye Primer Manual Cycle Sequencing Kit is de...mers and high-resolution fluorescence scanners. Se...owed by standard slab gel electrophoresis and scan...uencing products. The kit components have been op...
SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
Biology Products: